title: The relevance of P2Y(12)-receptor gene variation for the outcome of clopidogrel-treated patients undergoing elective coronary stent implantation: a clinical follow-up.
authors.forename: Heleen J
authors.initials: HJ
authors.lastname: Bouman
authors.forename: Jochem W
authors.initials: JW
authors.lastname: van Werkum
authors.forename: Goran
authors.initials: G
authors.lastname: Rudež
authors.forename: Christian M
authors.initials: CM
authors.lastname: Hackeng
authors.forename: Frank W G
authors.initials: FW
authors.lastname: Leebeek
authors.forename: Hugo
authors.initials: H
authors.lastname: ten Cate
authors.forename: Jurriën M
authors.initials: JM
authors.lastname: ten Berg
authors.forename: Moniek P M
authors.initials: MP
authors.lastname: de Maat
mesh_terms: D000244:Adenosine Diphosphate / Q000737:chemistry; D000368:Aged; D001241:Aspirin / Q000494:pharmacology; D000077144:Clopidogrel; D005260:Female; D005500:Follow-Up Studies; D014644:Genetic Variation; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000235:genetics / Q000401:mortality; D010974:Platelet Aggregation; D020641:Polymorphism, Single Nucleotide; D058921:Purinergic P2Y Receptor Antagonists / Q000494:pharmacology; D058925:Receptors, Purinergic P2Y12 / Q000737:chemistry*; D012984:Software; D015607:Stents / Q000009:adverse effects*; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000494:pharmacology
chemical_list: C548576:P2RY12 protein, human; D058921:Purinergic P2Y Receptor Antagonists; D058925:Receptors, Purinergic P2Y12; D000244:Adenosine Diphosphate; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin